Market Overview - The medical device sector experienced a decline of 0.74% on December 29, with Huakang Clean leading the drop [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Top Performers - Meihao Medical (301363) saw a closing price of 25.04, with an increase of 8.30% and a trading volume of 197,100 shares, totaling a transaction value of 482 million yuan [1] - Mailande (688273) closed at 41.73, up 8.22%, with a trading volume of 55,200 shares and a transaction value of 227 million yuan [1] - Kangzhong Medical (688607) closed at 45.80, up 7.23%, with a trading volume of 40,200 shares and a transaction value of 180 million yuan [1] Underperformers - Huakang Clean (301235) closed at 39.21, down 8.54%, with a trading volume of 123,300 shares and a transaction value of 488 million yuan [2] - C Jianxin (688805) closed at 47.16, down 7.26%, with a trading volume of 89,000 shares and a transaction value of 426 million yuan [2] - Furuim Medical (300049) closed at 71.93, down 4.20%, with a trading volume of 66,800 shares and a transaction value of 485 million yuan [2] Capital Flow - The medical device sector saw a net outflow of 565 million yuan from institutional investors, while retail investors experienced a net inflow of 328 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Meihao Medical (301363) had a net outflow of 54.30 million yuan from institutional investors, with retail investors also showing a net outflow of 0.76 million yuan [3] - Jigaofazhan (600807) experienced a net inflow of 44.75 million yuan from institutional investors, while retail investors had a net outflow of 61.29 million yuan [3] - Kangzhong Medical (688626) saw a net inflow of 44.26 million yuan from institutional investors, with retail investors showing a slight net outflow [3]

12月29日，A股三大指数早盘冲高回落，午后震荡走低，截止收盘，沪指涨0.04%报3965.28点，连续九 日走高，深成指跌0.49%报13537.1点，创业板指跌0.66%报3222.61点，科创50指数涨0.04%报1346.32 点；沪深两市成交额2.14万亿，全市场超3300只个股下跌。 脑机接口概念表现活跃，海格通信、喜临门等涨停，翔宇医疗、麦澜德、三博脑科、创新医疗等跟涨。 消息面上，12月28日，第五届脑科学前沿与产业大会暨2025深圳脑机接口博览会启幕，"粤港澳大湾区 脑科学与中枢神经疾病AI创新联盟"正式启动。 盘面上，机器人概念午后反复活跃，上纬新材、步科股份20cm涨停创历史新高，五洲新春、模塑科技 等多股涨停。商业航天概念延续强势，神剑股份8连板，金风科技、雷科防务等十余股涨停。碳纤维概 念表现活跃，吉林化纤、和顺科技双双涨停；锂矿概念下挫，欣旺达跌逾11%；医药商业板块走弱，漱 玉平民跌超18%；氟化工板块回调，漱玉平民跌逾8%；电池概念午后震荡下挫，华盛锂电跌超7%；电 力板块持续走弱，国电电力跌近8%。 热点板块 商业航天概念延续强势 商业航天概念延续强势，10余只成分股涨停，神 ...

格隆汇12月29日｜A股市场脑机接口板块集体走强，其中，翔宇医疗涨超9%，三博脑科、美好医疗、 麦澜德、创新医疗涨超6%，喜临门、普利特、博拓生物涨超5%。消息面上，12月28日，第五届脑科学 前沿与产业大会暨2025深圳脑机接口博览会启幕，"粤港澳大湾区脑科学与中枢神经疾病AI创新联盟"正 式启动。 ...

Investment Rating - The report maintains an "Overweight" rating for the biomedical sector [4] Core Insights - The brain-computer interface (BCI) industry is at a critical stage of policy support, rapid technological iteration, and accelerated commercialization, with a global market approaching $10 billion [3][9] - The industry is driven by both policy and technology, with significant investments from major countries, including approximately $4.5 billion from the U.S. BRAIN Initiative and hundreds of billions in China [1][51] - The medical application of BCI technology is the most mature segment, focusing on neurorehabilitation, functional replacement, and disease treatment, with a dual growth curve emerging from medical and consumer applications [2][45] Summary by Sections Industry Overview - BCI is defined as a technology that creates a communication channel between the brain and external devices, enabling direct information exchange [16] - BCI can be categorized into invasive, semi-invasive, and non-invasive types, each with distinct applications in medical rehabilitation, consumer interaction, and military use [17][19] - The global BCI market is projected to grow from $1.2 billion in 2019 to approximately $7.63 billion by 2029, with a compound annual growth rate (CAGR) exceeding 13% [24] Policy Guidance - Major countries have launched BCI-related initiatives, with the U.S. and EU leading in funding and research efforts [52][53] - China's "Brain Plan" aims to enhance brain science and BCI technology, with significant funding expected in the coming years [54][57] Clinical Applications - The medical sector is the primary focus for BCI applications, with significant demand driven by conditions such as stroke and disabilities [45][48] - Clinical trials for BCI products are accelerating globally, with notable advancements in both invasive and non-invasive technologies [3][19] Industry Progress - The report highlights the competitive landscape, noting that while foreign companies like Neuralink and Synchron have a head start, domestic firms are making significant strides in key areas such as flexible electrodes and real-time language decoding [2][4][30] - The BCI industry is characterized by a complex supply chain, with upstream components like electrodes and chips, midstream product supply, and downstream applications across various sectors [30][33] Investment Recommendations - Investors are advised to focus on companies with strong technological barriers and clinical application capabilities, particularly in the medical sector, which is the most developed area for BCI commercialization [3][9] - Specific companies to watch include medical scene integrators and leaders in invasive/semi-invasive technologies, such as Xiangyu Medical, Weisi Medical, and Brain Tiger Technology [3][9]

证券之星消息，12月25日医疗器械板块较上一交易日上涨1.35%，赛诺医疗领涨。当日上证指数报收于 3959.62，上涨0.47%。深证成指报收于13531.41，上涨0.33%。医疗器械板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 688108 | 赛诺医疗 | 20.43 | 14.90% | 60.98万 | | 12.21亿 | | 920925 | 锦好医疗 | 33.03 | 12.81% | 3.84万 | | 1.23亿 | | 688273 | 麦澜德 | 40.38 | 12.07% | 5.48万 | | 2.16亿 | | 688013 | 天臣医疗 | 52.94 | 11.10% | - 3.12万 | | 1.57亿 | | 688626 | 翔宇医疗 | 57.47 | 6.80% | 5.34万 | | 3.05亿 | | 688399 | 硕世生物 | 72.00 | 6.49% | 3.48万 | | 2.47亿 | ...

东北证券指出，2026年有望成为中国医疗器械板块的价值重构年。政策压力并非行业的终点：外有投资 回收期缩短、医院现金流改善促进采购决策，叠加医保/DRG政策优化预期；内有倒逼厂商创新+出海双 线并行；有望开启创新技术加速兑现、全球影响力持续提升的新发展阶段。当前，板块基本面已现拐 点，但机构持仓却处于近年历史低位，或可关注预期差下的投资机遇。 12月25日午后，三大指数集体拉升，白酒、医疗器械等多个低位板块走强。医疗器械指数ETF （159898）盘中上涨1.29%，据iFind数据，盘中该ETF申购3600万份。成分股方面，赛诺医疗涨超 14%，麦澜德涨超11%，伟思医疗、硕世生物等涨超7%，迈瑞医疗、联影医疗、奕瑞科技等多个权重股 走强。 消息面上，第六批国家高价值耗材集采启动，引入多重机制防止恶意低价。据智通财经12月23日报道， 新一批国家组织高值医用耗材集采正式启动，将对药物涂层球囊类、泌尿介入类医用耗材进行集采，于 2026年1月13日开标。与前五轮高值医用耗材的集中采购不同，此轮集采有两个新亮点：一是引入了锚 点价格的概念，二是引入了多重复活机制。 此外，据中国证券报，12月25日，国家药监局《 ...

【12月25日A股机器人概念股掀涨停潮】12月25日，A股市场机器人概念股表现活跃，掀起涨停潮。昊 志机电收获20CM涨停，超捷股份涨幅超17%。拓斯达、埃夫特涨超13%，成都华微涨超12%，麦澜德 涨超11%。创元科技、泰尔股份等多股实现10CM涨停。 本文由 AI 算法生成，仅作参考，不涉投资建议，使用风险自担 ...

| 300660 | 江苏雷 | 7.06 | 3.23 | 50.65 | 52.30 | 3.27 | | --- | --- | --- | --- | --- | --- | --- | | | 利 | | | | | | | 920580 | 科创新 | 6.81 | 9.94 | 15.84 | 16.31 | 2.97 | | | 材 | | | | | | | 603004 | 鼎龙科 技 | 3.54 | 5.25 | 23.30 | 23.97 | 2.86 | | 603036 | 如通股 份 | 5.92 | 2.67 | 20.02 | 20.56 | 2.71 | | 300733 | 西菱动 力 | 9.17 | 7.48 | 19.14 | 19.65 | 2.67 | | 301062 | 上海艾 | 5.24 | 6.00 | 8.41 | 8.63 | 2.66 | | | 录 | | | | | | | 300973 | 立高食 | 2.36 | 1.98 | 43.62 | 44.63 | 2.31 | | | 品 | | | | | | | 300988 | 津荣天 ...

12月25日早盘，养老概念震荡走强。截至9时54分，益民集团涨停。麦澜德涨超7%，翔宇医疗、雷科防 务涨逾5%。 上证报中国证券网讯 12月25日早盘，养老概念震荡走强。截至9时54分，益民集团涨停。麦澜德涨超 7%，翔宇医疗、雷科防务涨逾5%。 | 代码 | 名称 | | | 涨幅% J | 涨跌 | | --- | --- | --- | --- | --- | --- | | 600824 | 益民集团 | 1 | 5.16 | 10.02 | 0.47 | | 688273 | 麦澜德 | 1 | 38.56 | 7.02 | 2.53 | | 688626 翔宇医疗 | | 1 | 56.80 | 5.56 | 2.99 | | 002413 | 雷科防务 | 1 | 9.44 | 5.47 | 0.49 | | 600735 ST新华锦 | | | 5.04 | 5.00 | 0.24 | | 300247 | 融捷健康 | I | 5.01 | 3.51 | 0.17 | | 601318 | 中国平安 | 1 | 71.45 | 3.51 | 2.42 | | 603666 亿嘉和 | | | ...

麦澜德(688273.SH)公告称，麦澜德在投资者关系活动中透露，公司已与荣脑科技建立战略合作关系， 合作具有排他性，荣脑科技为公司医疗场景下的产品开发提供技术支持。公司预计在2026年一季度获得 首张脑机接口医疗器械注册证（脑机接口经颅磁刺激仪）。多模态脑机接口技术融合了脑电和近红外光 信号，具有临床可用性高、能更立体精准解析大脑状态的优势。 ...